Changes of Serum TNF-α in Acute Pancreatitis Patients and Its Clinical Significance
Abstract
Objective: The aimed of this study is to investigate the changes in serum levels of tumor necrosis factor (TNF-α) in the patients with acute pancreatitis treated with octreotide and its clinical significance. Method: Total of 65 patients of acute pancreatitis were selected as a case study, in which 30 patients with mild acute pancreatitis (MAP) and 35 severe acute pancreatitis (SAP) patients were treated with octreotide. 60 healthy subjects as control group and 65 case group was subjected to performed double antibody sandwich enzyme-linked immunosorbent assay (ELISA) to detect the serum levels of TNF-α. Results: The serum TNF-α level in the case group was (12.67 ± 3.45) pg/mL and the control group was (1.56 ± 0.57) pg/mL. Case group was significantly higher than control group (p < 0.05). Serum level of acute pancreatitis (AP) before treatment was (8.96 ± 2.12) pg/mL. After treatment, SAP group was (17.34 + 4.56) pg/mL, MAP group was significantly lower than SAP group, and the difference was statistically significant (p < 0.05). Conclusion: The serum levels of TNF-α in patient with acute pancreatitis were significantly higher than those of normal healthy people, and their serum level was closely related to the severity of illness.
References
2. Lu H, Shi Z, Paul L. Changes of serum TNF-α, IL-1 and IL-6 in patients with acute pancreatitis associated lung injury and their clinical significance. Chongqing Medicine. 2007:36(18):1818‒1819.
3. Tan S, Zeng Q, Liao Y et al. Changes of serum tumor necrosis factor alpha and soluble E- in patients with acute pancreatitis and clinical significance. Practical Medicine. 2009:25(17):2859‒2861.
4. Yang Y. 40 cases of severe acute pancreatitis treated with magnesium sulfate Hainan Medicine. 2011:22 (22):34‒35.
Copyright (c) 2015 Wenrui Yang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.